T. Shibata

发表

A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)

Kenji Suzuki, H. Kato, M. Tsuboi, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503.

I. Konishi, T. Kamura, T. Shibata, 2012, Japanese journal of clinical oncology.

Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer.

S. Fukuhara, T. Habuchi, O. Ogawa, 2008, Japanese journal of clinical oncology.

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404

T. Shien, H. Iwata, T. Kinoshita, 2014, Cancer Chemotherapy and Pharmacology.

Radiographically determined noninvasive adenocarcinoma of the lung: survival outcomes of Japan Clinical Oncology Group 0201.

Masahiko Kusumoto, Masahiro Tsuboi, Hisao Asamura, 2013, The Journal of thoracic and cardiovascular surgery.

A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211)

Kenji Suzuki, H. Katayama, H. Saji, 2017, General Thoracic and Cardiovascular Surgery.

Small cell lung cancer and other thoracic malignancies

M. Nishimura, Y. Hosomi, M. Shibuya, 2012 .

A Randomized Controlled Trial of the Conventional Technique Versus the No-touch Isolation Technique for Primary Tumor Resection in Patients with Colorectal Cancer: Japan Clinical Oncology Group Study JCOG1006

H. Katayama, Y. Shimada, Y. Moriya, 2013, Japanese journal of clinical oncology.

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan

N. Ohmagari, Y. Asai, S. Tsuzuki, 2022, Infectious Diseases and Therapy.

Japanese universal health care faces a crisis in cancer treatment.

K. Yonemori, Y. Fujiwara, N. Okita, 2015, The Lancet. Oncology.

Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

S. Mandrekar, N. Saijo, D. Gandara, 2015 .

A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non–small cell lung cancer (JCOG 0707)

Kenji Suzuki, M. Tsuboi, M. Okada, 2020, JTCVS open.

A single-arm confirmatory study of amrubicin therapy in patients with refractory small-cell lung cancer: Japan Clinical Oncology Group Study (JCOG0901).

Y. Ichinose, Y. Ohe, K. Kiura, 2014, Lung cancer.

Cisplatin (Cis)/etoposide (VP16) compared to cis/irinotecan (CPT11) in extensive-stage small cell lung cancer (E-SCLC): Pharmacogenomic (PG) and comparative toxicity analysis of JCOG 9511 and SWOG 0124

N. Saijo, D. Gandara, H. Lenz, 2007 .

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'

T. Kasamatsu, H. Yoshikawa, T. Yasugi, 2013, British Journal of Cancer.

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

N. Saijo, Y. Ichinose, Y. Ohe, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124.

N. Saijo, D. Gandara, K. Chansky, 2010, Cancer.

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.

M. Hatae, H. Yoshikawa, T. Onda, 2009, Gynecologic oncology.

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

N. Saijo, S. Kudoh, H. Kunikane, 2007, British Journal of Cancer.

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study

Y. Kagami, M. Ogura, J. Kuroda, 2020, Cancer science.

A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413).

M. Okada, H. Saji, H. Asamura, 2018, Japanese journal of clinical oncology.

Evaluation of radiologic diagnosis in peripheral clinical IA lung cancers-A prospective study for radiological diagnosis of peripheral early lung cancer (JCOG 0201).

M. Tsuboi, M. Kusumoto, H. Asamura, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

臨床IA期末梢型非小細胞肺癌における放射線学的診断の評価:末梢型早期肺癌の放射線学的診断の前向き研究(JCOG0201)

M. Tsuboi, M. Kusumoto, H. Asamura, 2006 .

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan

M. Kami, H. Narimatsu, T. Shibata, 2007, Cancer.

Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019.

T. Tsuzuki, N. Shinohara, H. Kitamura, 2012, Japanese journal of clinical oncology.

A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403)

R. Onimaru, E. Kunieda, H. Onishi, 2010 .

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702).

R. Onimaru, H. Shirato, H. Onishi, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

SY1. building the foundation for investigator-initiated clinical trial

P. Jänne, H. Katayama, M. Kudo, 2012 .

Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV⩾100cc.

R. Onimaru, H. Shirato, H. Onishi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical Trials in Japan After Implementation of the International Conference on Harmonization — Good Clinical Practice (ICH-GCP) Guidelines

T. Shibata, K. Tsutani, K. Kimura, 2003 .

Prevalence of Anemia among Healthy Women in 2 Metropolitan Areas of Japan

M. Kami, K. Yuji, T. Shibata, 2006, International journal of hematology.

Dose-Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC) With PTV ≥ 100 cm3: Japan Clinical Oncology Group Study (JCOG0702)

Yoichi M. Ito, R. Onimaru, H. Shirato, 2015 .

Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial.

M. Taniwaki, S. Nawano, M. Ogura, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis.

N. Yaegashi, M. Ishikawa, T. Shibata, 2021, Gynecologic oncology.

A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505).

H. Yoshikawa, I. Konishi, T. Kamura, 2010, Japanese journal of clinical oncology.

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in phase III randomized trial: JCOG0602.

T. Kasamatsu, K. Ushijima, H. Yoshikawa, 2014 .

A phase-II trial of dose-dense chemotherapy in patients with disseminated thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9605)

N. Saijo, Y. Nishiwaki, T. Tamura, 2009, British Journal of Cancer.

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)

N. Saijo, Y. Nishiwaki, M. Nishio, 2009, British Journal of Cancer.

Evaluation of three definitions of progression-free survival in preoperative cancer therapy (JCOG0801-A).

Seiichiro Yamamoto, A. Takashima, T. Shibata, 2012, Japanese journal of clinical oncology.

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.

K. Yonemori, C. Shimizu, Y. Fujiwara, 2006, Pathology, research and practice.

Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.

Y. Tomita, S. Naito, Yoshihiko Tomita, 2014, Annals of Oncology.

Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation

Haruko Yamamoto, H. Hanaoka, N. Okita, 2021, Therapeutic Innovation & Regulatory Science.

Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease

M. Kami, Y. Shibagaki, Y. Yamaguchi, 2008, International journal of hematology.

A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906

Y. Nishimura, M. Hiraoka, Y. Nagata, 2018, Japanese journal of clinical oncology.

Stereotactic Body Radiation Therapy For T1N0M0 Non-small Cell Lung Cancer: First Report for Inoperable Population of a Phase II Trial by Japan Clinical Oncology Group (JCOG 0403)

R. Onimaru, H. Onishi, Y. Shioyama, 2012 .

MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial

Toshio Shimizu, K. Yonemori, Y. Fujiwara, 2020, Clinical pharmacology and therapeutics.

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.

A. Sato, H. Yoshikawa, T. Onda, 2008, Japanese journal of clinical oncology.

Immunologic Phenotype of Tumor Cells from Japanese T Cell Malignancies

K. Tobinai, T. Shibata, M. Nagai, 1984 .

A non-randomized confirmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer: Japan Clinical Oncology Group Study (JCOG1203).

H. Tsuda, T. Baba, K. Ushijima, 2015, Japanese journal of clinical oncology.

A non-randomized con fi rmatory study regarding selection of fertility-sparing surgery for patients with epithelial ovarian cancer : Japan Clinical Oncology Group Study ( JCOG 1203 )

H. Tsuda, T. Baba, K. Ushijima, 2015 .

Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis

T. Shibata, J. Sato, T. Kihira, 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Safety and efficacy trial of cisplatin (P) with vinorelbine (V) followed by gefitinib (G) and concurrent thoracic radiotherapy (TRT) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC): Japan Clinical Oncology Group (JCOG) 0402.

N. Saijo, Y. Nishiwaki, Y. Ohe, 2010 .

Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced‐intensity cord blood transplantation

M. Kami, H. Narimatsu, K. Yuji, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

K. Ushijima, H. Yoshikawa, I. Konishi, 2016, Cancer Chemotherapy and Pharmacology.

Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104).

N. Saijo, Y. Nishiwaki, M. Ando, 2009, Annals of Oncology.

Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.

A. Rossi, C. Gridelli, W. Qian, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement

T. Shibata, M. Monden, R. Ueda, 2018, Cancer science.

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

M. Yunokawa, I. Konishi, T. Kamura, 2015, Gynecologic oncology.

A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

M. Tsuboi, M. Okada, H. Saji, 2010, Japanese journal of clinical oncology.

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).

T. Kasamatsu, T. Onda, T. Kamura, 2015, Japanese journal of clinical oncology.

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma

K. Yonemori, Y. Fujiwara, K. Tamura, 2018, Therapeutic innovation & regulatory science.

Non-randomized confirmatory trial of modified

T. Kasamatsu, T. Onda, T. Shibata, 2014 .

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.

K. Mori, Y. Ohe, K. Kiura, 2016, The Lancet. Oncology.

Phase III study comparing amrubicin plus cisplatin with irinotecan plus cisplatin in the treatment of extensive-disease small-cell lung cancer: JCOG 0509.

N. Saijo, Y. Ichinose, Y. Ohe, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Common arm comparative outcomes analysis of phase III trials of cisplatin + irinotecan vs. cisplatin + etoposide in extensive stage small cell lung cancer: Final patient-level results from JCOG 9511 and SWOG 0124

N. Saijo, D. Gandara, K. Chansky, 2011 .

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer 1

N. Saijo, D. Gandara, K. Chansky, 2010 .

Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.

N. Saijo, K. Kubota, M. Nishio, 2014, The Lancet. Oncology.

Choice of control group in efficacy-showing clinical trials in Japan: does the ICH-E10 guideline change conventions?

Shunsuke Ono, Hiroyuki Uesaka, Toshihiko Morikawa, 2002, International Journal of Pharmaceutical Medicine.

A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201).

Y. Ohe, T. Shibata, J. Eba, 2015, Japanese journal of clinical oncology.

A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).

M. Tsuboi, H. Katayama, H. Asamura, 2014, Japanese journal of clinical oncology.

Rare cancers in Japan: definition, clinical features and future perspectives.

Y. Fujiwara, T. Nishida, T. Higashi, 2020, Japanese journal of clinical oncology.

Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L.

N. Saijo, Y. Ichinose, Y. Ohe, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of watchful waiting vs. rituximab as first-line treatment in advanced stage follicular lymphoma with low tumour burden (JCOG1411, FLORA study).

D. Maruyama, K. Ishizawa, K. Tsukasaki, 2018, Japanese journal of clinical oncology.

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)

H. Uchi, M. Furue, N. Yamazaki, 2017, Japanese journal of clinical oncology.

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

T. Kasamatsu, K. Ushijima, H. Yoshikawa, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MASTER KEY project: A basket/umbrella trial for rare cancers in Japan.

K. Yonemori, T. Shibata, A. Kawai, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

N. Saijo, Y. Ohe, N. Yamamoto, 2012, The Lancet. Oncology.

Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)

T. Sano, M. Sasako, Y. Kurokawa, 2014, Gastric Cancer.

A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)

M. Tsuboi, M. Okada, H. Asamura, 2008, British Journal of Cancer.

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

T. Kasamatsu, H. Yoshikawa, T. Yasugi, 2013, British Journal of Cancer.

Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

R. Onimaru, E. Kunieda, H. Onishi, 2015, International journal of radiation oncology, biology, physics.

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)

N. Saijo, Y. Nishiwaki, T. Tamura, 2010, British Journal of Cancer.

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

Yasuhiro Fujiwara, Tsutomu Kouno, Yasuhiro Yamanaka, 2006, Journal of Cancer Research and Clinical Oncology.

Final Results of a Safety and Efficacy Trial of Preoperative Sequential Chemoradiation Therapy for the Nonsurgical Treatment of Early Breast Cancer: Japan Clinical Oncology Group Study JCOG0306

H. Iwata, H. Tsuda, H. Mukai, 2013, Oncology.

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors

Y. Ando, Y. Hirashima, T. Shibata, 2016, Cancer Chemotherapy and Pharmacology.

Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study: Japan Clinical Oncology Group study (JCOG 0701).

M. Hiraoka, T. Kodaira, T. Shibata, 2008, Japanese journal of clinical oncology.

Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.

H. Nishiyama, N. Nishiyama, T. Kojima, 2020, Japanese journal of clinical oncology.

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

R. Ueda, K. Yamaguchi, M. Tomonaga, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long‐term survivors of aggressive adult T‐cell leukaemia‐lymphoma (JCOG0902A)

S. Nomura, K. Uozumi, A. Utsunomiya, 2014, British journal of haematology.

Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.

M. Kurosawa, K. Tobinai, K. Tsukasaki, 2012, Japanese journal of clinical oncology.

Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma : Japan Clinical Oncology Group Study , JCOG 9402

M. Kurosawa, K. Tobinai, K. Tsukasaki, 2012 .

Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)

R. Ueda, M. Ogura, T. Kinoshita, 2013, Leukemia & lymphoma.

Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial).

H. Katayama, T. Hamaguchi, Y. Kanemitsu, 2019, Japanese journal of clinical oncology.

Phase II/III Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab (R-CHOP) Versus Biweekly CHOP with Rituximab (R-Bi-CHOP) In Untreated Advanced-Stage Indolent B-Cell Lymphoma: Japan Clinical Oncology Group (JCOG) 0203 Trial

M. Taniwaki, S. Nawano, M. Ogura, 2010 .

Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207†.

N. Saijo, Y. Ohe, M. Ando, 2015, Japanese journal of clinical oncology.

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)

T. Maeda, N. Yamazaki, Y. Teramoto, 2020, BMC Cancer.

Which is the Optimal Response Criteria for Evaluating Preoperative Treatment in Esophageal Cancer: RECIST or Histology?

H. Mukaida, Y. Kurokawa, T. Shibata, 2013, Annals of Surgical Oncology.

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809.

R. Ueda, S. Nakamura, M. Ogura, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)

Y. Nishimura, M. Hiraoka, T. Teshima, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)

Y. Nishimura, M. Yoshimura, M. Hiraoka, 2020, International Journal of Clinical Oncology.

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

N. Saijo, Y. Ichinose, M. Fukuoka, 2012 .

Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

N. Ohmagari, Y. Asai, S. Tsuzuki, 2022, International Journal of Infectious Diseases.

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan

W. Sugiura, H. Ohtsu, N. Ohmagari, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Role of Adjuvant Chemotherapy for Localized Squamous Cell Esophageal Cancer: Current Japanese Standard and the Unending Role of the Drawing Board

T. Shibata, N. Ando, Kenichi Nakamura, 2012, Annals of Surgical Oncology.

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802).

T. Tabei, S. Takashima, N. Masuda, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.

H. Kato, M. Tsuboi, H. Asamura, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE).

Y. Ouchi, Y. Ohashi, H. Orimo, 2006, Current therapeutic research, clinical and experimental.

Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan

Yoshiaki Uyama, Hideki Hanaoka, S. Toyoshima, 2005, Clinical pharmacology and therapeutics.

The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

T. Shien, D. Rea, H. Iwata, 2019, Journal of Clinical Oncology.

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

T. Shien, C. Shimizu, T. Kinoshita, 2008, Breast Cancer Research and Treatment.

Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401)

T. Shien, H. Iwata, T. Kinoshita, 2014, International Journal of Clinical Oncology.

Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.

H. Nishiyama, N. Nishiyama, T. Kojima, 2020, Japanese journal of clinical oncology.

Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study

H. Ohtsu, N. Ohmagari, Y. Asai, 2022, The Lancet Regional Health - Western Pacific.

Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan

W. Sugiura, H. Ohtsu, N. Ohmagari, 2021, medRxiv.

A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017.

T. Shien, H. Iwata, T. Kinoshita, 2012, Japanese journal of clinical oncology.

Frequency and clinicopathological characteristics of biliary tract carcinomas harboring the FGFR2-fusion gene: A prospective observational study (PRELUDE study)

T. Yamanaka, A. Miyamoto, Y. Arai, 2019, Annals of Oncology.

Regulatory changes after the enforcement of the new Clinical Trials Act in Japan

T. Shibata, Kenichi Nakamura, 2020, Japanese Journal of Clinical Oncology.

Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)

S. Fukushima, N. Yamazaki, S. Matsushita, 2019, BMC Cancer.

Confirmatory trial of non-amputative digit preservation surgery in subungual melanoma: JCOG1602 (J-NAIL study).

Y. Fujisawa, N. Yamazaki, S. Matsushita, 2018 .

New drug approval times and clinical evidence in Japan.

T. Shibata, O. Asaka, S. Ono, 2005, Contemporary clinical trials.

Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol)

S. Fukushima, N. Yamazaki, S. Matsushita, 2019, BMC Cancer.

Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.

F. Hara, H. Iwata, T. Kinoshita, 2015, Japanese journal of clinical oncology.

Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)

Y. Ohe, Toshiaki Takahashi, N. Yamazaki, 2020, Supportive Care in Cancer.

Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).

T. Kasamatsu, Y. Nishimura, Hiroyuki Okamoto, 2019, Japanese journal of clinical oncology.

Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).

H. Katayama, H. Watari, N. Sakuragi, 2017, Japanese journal of clinical oncology.

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis.

H. Katayama, T. Shibata, J. Mizusawa, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A meta-analysis of randomized controlled trials of intracoronary gamma- and beta-radiation therapy for in-stent restenosis

R. Kuntz, T. Shibata, A. Bakhai, 2006, Heart and Vessels.

Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311)

N. Yaegashi, M. Ishikawa, T. Shibata, 2023, International Journal of Gynecological Cancer.

A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311).

N. Yaegashi, M. Ishikawa, T. Shibata, 2018, Japanese journal of clinical oncology.

A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC).

T. Hamaguchi, Y. Shimada, Y. Moriya, 2011, Japanese journal of clinical oncology.

A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial).

Y. Nishimura, M. Hiraoka, T. Kimura, 2017, Japanese journal of clinical oncology.

Randomized controlled trial comparing docetaxel (D)-cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207

N. Saijo, Y. Nishiwaki, Y. Ohe, 2007 .

Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): An intergroup trial of JCOG0803/WJOG4307L.

N. Saijo, Y. Ichinose, Y. Ohe, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antimicrobial prophylaxis for 1 day versus 3 days in liver cancer surgery: a randomized controlled non-inferiority trial

M. Oka, S. Kubo, M. Shimada, 2019, Surgery Today.

Comment on “Biostatistical Considerations When Using RWD and RWE in Clinical Studies for Regulatory Purposes: A Landscape Assessment”

S. Nomura, T. Shinozaki, Y. Uemura, 2021, Statistics in Biopharmaceutical Research.

Accuracy of preoperative imaging diagnosis as a possible new staging system in advanced ovarian, tubal, and peritoneal cancer: Using data from Japan Clinical Oncology Group study JCOG0602.

T. Kasamatsu, H. Yoshikawa, T. Onda, 2016 .

Immunohistochemical identification of prostate-specific antigen in a parameatal urethral cyst of the glans penis.

T. Shibata, N. Ichiyanagi, T. Matsumura, 1998, British journal of urology.

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)

T. Maeda, K. Yokota, N. Yamazaki, 2020, BMC Cancer.

A randomized phase III study of cisplatin (CDDP), etoposide (ETOP) and irinotecan versus topotecan as second-line chemotherapy in patients with sensitive relapsed small-cell lung cancer (SCLC): Japan Clinical Oncology Group study JCOG0605

K. Mori, Y. Ohe, K. Kiura, 2014 .

Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)

N. Yamazaki, T. Hamaguchi, Y. Kiyohara, 2021, Supportive Care in Cancer.

Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery

M. Tsuboi, M. Okada, N. Ikeda, 2023, JTO Clinical and Research Reports.

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Y. Ichinose, K. Takeda, T. Shibata, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.

M. Kurosawa, K. Tobinai, K. Tsukasaki, 2012, Japanese journal of clinical oncology.

A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (JCOG1017 PRIM-BC).

F. Hara, T. Shien, H. Iwata, 2017 .

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan

W. Sugiura, H. Ohtsu, N. Ohmagari, 2021, International Journal of Infectious Diseases.

Final analysis of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment (NST) in early breast cancer (EBC): Japan Clinical Oncology Group Trial (JCOG0306).

H. Tsuda, H. Mukai, A. Sato, 2010 .

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis.

T. Shibata, J. Mizusawa, J. Eba, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206).

M. Tsuboi, H. Katayama, H. Asamura, 2014, Japanese journal of clinical oncology.

Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial.

M. Taniwaki, S. Nawano, M. Ogura, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III study comparing amrubicin and cisplatin (AP) with irinotecan and cisplatin (IP) for the treatment of extended-stage small cell lung cancer (ED-SCLC): JCOG0509.

N. Saijo, Y. Ichinose, Y. Ohe, 2012 .

Difference between hematological malignancy and Solid tumor research articles published in four major medical journals

M. Kami, K. Yuji, Kazuhiko Kobayashi, 2006, Leukemia.

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

S. Mandrekar, E. Vokes, A. Adjei, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.

A. Gemma, T. Shibata, H. Asamura, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized, phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505).

K. Ushijima, H. Yoshikawa, M. Takano, 2012 .

S. Naito, H. Fujimoto, N. Masumori, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

COCIS individual patient data (IPD) meta-analysis: Carboplatin- or cisplatin-based chemotherapy (CT) as first-line treatment of small cell lung cancer (SCLC).

C. Gridelli, F. Perrone, W. Qian, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.

K. Tobinai, T. Shibata, M. Nagai, 1983, Japanese journal of clinical oncology.

Updated results of a phase III trial comparing standard thoracic radiotherapy (RT) with or without concurrent daily low-dose carboplatin in elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC): JCOG0301.

K. Mori, N. Saijo, Y. Ohe, 2012 .